Why is JSS a strategic partner for your COVID-19 study development?

The JSS COVID-19 Task Force

  • We have a designated team which keeps abreast of the latest developments pertaining to SARS-CoV-2

  • We have a deep understanding and are fully aware of the challenges involved in the current treatment processes and testing protocols according to the regulations of various states and provinces

  • Scientific Affairs Group
    • COVID-19 Standard of Care and Competing Studies
    • COVID-19 Synopsis and Protocol Templates

  • Feasibility and Recruitment
    • We are securing potential sites in strategic territories
    • We are remaining up-to-date with changing patient availability
    • We are aware of differentiations between hospitals (Canada vs US), CHSLDs, long-term care facilities and SMOs

Corporate Overview

JSS Medical Research is a full-service CRO built on a foundation of epidemiological and scientific expertise, with a strong network of academic affiliations and over 30 years of experience in multiple therapeutic areas.

We are an international Canadian-owned company with offices in Canada, the USA, Colombia, India and Poland. We have over 200 ongoing projects in fiscal 2020 and are present in more than 20 countries with approximately 300 full time employees.

Comprehensive services provided globally by JSS Medical Research support pharmaceutical, biotechnology, nutraceutical and medical device companies with their pre- and post-approval clinical development as well as reimbursement goals and strategies.

Meet our Executive Team

Louise Bussières, CPA

President and Chief Financial Officer

Stella Boukas, B.A., CCRP

Chief Operations Officer

Emmanouil Rampakakis, Ph.D.

Executive Vice-President

Marianna Boukas, B.A.

Senior Director of Quality Assurance

Jimmy Fragos

Global Director of Bioinformatics

Yohana Paola Granados, M.Sc.

Director of Clinical Operations – Latin America

Dr. Ajoy Kumar

Country Head, JSS Medical Research Ltd. - India

Dr. Renu Razdan

Vice President, Operations - India


A Timeline of Our History

  • 1985

    JSS Medical Research was founded in 1985 by Dr. John S. Sampalis. The company began as a university-based group providing consulting services to pharmaceutical companies focusing on medical writing and statistical analysis.

  • 1997

    Service offerings were expanded to include clinical operations and information technology (IT) solutions.

  • 2005

    An internal quality assurance department was added which implemented a Quality Assurance Program under the direction of compliance specialists from SNC Lavalin Pharma. Since then, the QA Program has been managed internally, with SNC Lavalin Pharma acting as third party auditors and consultants.

  • 2006

    Since 2006, JSS Medical Research has operated as a full service CRO adding quality assurance, study monitoring and training to its services.

  • 2012

    Offering expansion in health economics and outcomes research, providing reimbursement strategy services and leveraging health economics expertise to build the key elements of reimbursement submissions.

  • 2013

    In September, 2013 a new office (JSS Medical Research Colombia S.A.S.) was opened in Bogotá, Colombia following the acquisition of Latam Clinical Trials.

  • 2014

    The company consolidates its position in Canada by merging with Integrated Research Inc.

  • 2015

    The acquisition of Max Neeman International represents a significant step in the company’s growth in the Asia/Pacific region.

  • 2016

    In May 201, JSS Medical Research acquired Bonne Santé, CRO in Poland to accelerate the expansion into Europe.

  • Today

    Today, JSS Medical Research is one of the largest Canadian-owned CROs in Canada with approximately 300 full time employees and 50 contractual-based consultants, mainly clinical research associates and clinical research coordinators.

+ -